Intestinal fatty acid binding protein (I-FABP) as a sensitive and specific biomarker for necrotizing enterocolitis (NEC) in pre-term infants
Topic overview
This study evaluates intestinal fatty acid binding protein (I-FABP) as a diagnostic biomarker to distinguish necrotizing enterocolitis from other conditions with similar clinical presentations in preterm neonates. The research aims to establish I-FABP's sensitivity and specificity for NEC diagnosis, potentially enabling earlier detection and intervention in this life-threatening intestinal disease.
Key takeaways
- I-FABP plasma levels are elevated in neonates with necrotizing enterocolitis compared to healthy controls.
- I-FABP may serve as a specific biomarker to differentiate NEC from other conditions with similar clinical presentations.
- Early biomarker detection could enable timely intervention before advanced intestinal necrosis develops.
- I-FABP specificity for intestinal injury makes it superior to non-specific inflammatory markers in NEC diagnosis.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Intestinal fatty acid binding protein (I-FABP) as a sensitive and specific biomarker for necrotizing enterocolitis (NEC) in pre-term infants. GlobalCastMD Medical Library. 2025-10-21. https://library.globalcastmd.com/article/11195
Comments